Literature DB >> 3750278

Quantitation of urokinase antigen in plasma and culture media by use of an ELISA.

D J Binnema, J J van Iersel, G Dooijewaard.   

Abstract

An ELISA was set up using polyvinylchloride microtiter plates coated with rabbit anti-UK IgG's and affino-purified goat anti-UK IgG's as second antibody. Detection occurred with rabbit anti-goat IgG antibodies conjugated with alkaline phosphatase. The assay is specific for urokinase (UK) with a detection limit of 100 pg/ml sample. Tissue-type plasminogen activator, up to concentrations of 100 ng/ml, does not interfere. The assay measures the antigen of the inactive zymogen pro-UK, the active enzyme UK and the UK-inhibitor complex with equal efficiency and gives the total UK antigen present, irrespective of its molecular form. Culture media of fibroblasts, endothelial- and kidney cells showed, despite the absence of active UK, antigen levels of 1.2, 23 and 65 ng/ml, respectively. In human plasma the UK concentration was found to be 3.5 +/- 1.4 ng/ml (mean +/- SD, n = 54). The inter- and intra-assay variations were 20% and 6%, respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3750278     DOI: 10.1016/0049-3848(86)90077-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  17 in total

1.  Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.

Authors:  P H Quax; N Pedersen; M T Masucci; E J Weening-Verhoeff; K Danø; J H Verheijen; F Blasi
Journal:  Cell Regul       Date:  1991-10

2.  Gastric mucosal plasminogen activators in Helicobacter pylori infection.

Authors:  J M Götz; Y Vergouwe; H W Verspaget; I Biemond; C F Sier; C B Lamers; R A Veenendaal
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

3.  Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase.

Authors:  J H Verheijen; N M Nieuwenbroek; B Beekman; R Hanemaaijer; H W Verspaget; H K Ronday; A H Bakker
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

4.  Reprogramming urokinase into an antibody-recruiting anticancer agent.

Authors:  Charles E Jakobsche; Patrick J McEnaney; Andrew X Zhang; David A Spiegel
Journal:  ACS Chem Biol       Date:  2011-11-18       Impact factor: 5.100

5.  Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

Authors:  T J de Vries; P H Quax; M Denijn; K N Verrijp; J H Verheijen; H W Verspaget; U H Weidle; D J Ruiter; G N van Muijen
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

6.  Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans.

Authors:  Tom van der Poll; Marcel Levi; Jerry A Nick; Edward Abraham
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

7.  Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.

Authors:  C F Sier; H W Verspaget; G Griffioen; S Ganesh; H J Vloedgraven; C B Lamers
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

8.  Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia.

Authors:  M J Schultz; J Millo; M Levi; C E Hack; G J Weverling; C S Garrard; T van der Poll
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

9.  Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood.

Authors:  D Menzel; M Levi; G Dooijewaard; M Peters; J W ten Cate
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

10.  Plasminogen activators in synovial fluid and plasma from patients with arthritis.

Authors:  E J Brommer; G Dooijewaard; B A Dijkmans; F C Breedveld
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.